UBL-29621-63578
4 vaccinations
1 coded response
36 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 058 / VT
- Registered
- 2020-12-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
M6D-29208-35859
Child or adolescent in my care · Male · 2022-08-03
Timeline
-
2020-12-17
Dose 1 — Pfizer-BioNTech
-
2020-12-18
Registered in v-safe
- 2020-12-18
- 2020-12-19
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-23
- 2020-12-24
- 2020-12-31
- 2021-01-07
-
2021-01-08
Dose 2 — Pfizer-BioNTech
- 2021-01-08
- 2021-01-09
- 2021-01-10
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-24
- 2021-01-29
- 2021-02-05
- 2021-02-12
- 2021-02-19
- 2021-04-11
- 2021-07-09
-
2021-10-06
Dose 3 — Pfizer-BioNTech
-
2022-01-08
Survey response — 12 months, dose 2MedDRA: Caesarean section — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: C sectionMedDRA releases: 2024-11 · check-in free text available
-
2022-01-08
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prHospitalization · 1 call case(s)
- 2022-01-10
-
2022-09-09
Dose 4 — Pfizer-BioNTech
-
2022-09-10
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2022-09-11
- 2022-09-12
- 2022-09-16
- 2022-09-23
- 2022-09-30
- 2022-10-07
- 2022-10-14
- 2022-10-21
- 2022-12-09
- 2023-03-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-17 | Pfizer-BioNTech | |
| 2 | 2021-01-08 | Pfizer-BioNTech | |
| 3 | 2021-10-06 | Pfizer-BioNTech | No |
| 4 | 2022-09-09 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 10 — 12 months, dose 2
Symptoms: C section
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Caesarean section | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release